These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15734144)

  • 1. Transcription factor cross-talk: the estrogen receptor and NF-kappaB.
    Kalaitzidis D; Gilmore TD
    Trends Endocrinol Metab; 2005 Mar; 16(2):46-52. PubMed ID: 15734144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crossroads of estrogen receptor and NF-kappaB signaling.
    Biswas DK; Singh S; Shi Q; Pardee AB; Iglehart JD
    Sci STKE; 2005 Jun; 2005(288):pe27. PubMed ID: 15956359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer.
    Biswas DK; Iglehart JD
    J Cell Physiol; 2006 Dec; 209(3):645-52. PubMed ID: 17001676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NFkappaB pathway and endocrine-resistant breast cancer.
    Zhou Y; Eppenberger-Castori S; Eppenberger U; Benz CC
    Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S37-46. PubMed ID: 16113098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway.
    Ciucci A; Gianferretti P; Piva R; Guyot T; Snape TJ; Roberts SM; Santoro MG
    Mol Pharmacol; 2006 Nov; 70(5):1812-21. PubMed ID: 16908599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells.
    Gionet N; Jansson D; Mader S; Pratt MA
    J Cell Biochem; 2009 Jun; 107(3):448-59. PubMed ID: 19350539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding.
    Van Laere SJ; Van der Auwera I; Van den Eynden GG; Elst HJ; Weyler J; Harris AL; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3249-56. PubMed ID: 16740744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of nuclear factor-kappaB in the immune system and bone.
    Jimi E; Ghosh S
    Immunol Rev; 2005 Dec; 208():80-7. PubMed ID: 16313342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-talk between nuclear receptors and nuclear factor kappaB.
    De Bosscher K; Vanden Berghe W; Haegeman G
    Oncogene; 2006 Oct; 25(51):6868-86. PubMed ID: 17072333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The nuclear factor kappa B activation: the key step of cell proliferation in estrogen receptor-negative breast cancer cells].
    Wang HJ; Wu ZY; Fan P; Bian JM
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):1014-6. PubMed ID: 16194364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-alpha enhances estrogen-induced cell proliferation of estrogen-dependent breast tumor cells through a complex containing nuclear factor-kappa B.
    Rubio MF; Werbajh S; Cafferata EG; Quaglino A; Coló GP; Nojek IM; Kordon EC; Nahmod VE; Costas MA
    Oncogene; 2006 Mar; 25(9):1367-77. PubMed ID: 16331275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the NF-kappa B pathway in estrogen receptor negative MDA-MB-231 breast cancer cells using small inhibitory RNAs.
    Monks NR; Pardee AB
    J Cell Biochem; 2006 May; 98(1):221-33. PubMed ID: 16408291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear factor-kappaB-dependent mechanisms in breast cancer cells regulate tumor burden and osteolysis in bone.
    Gordon AH; O'Keefe RJ; Schwarz EM; Rosier RN; Puzas JE
    Cancer Res; 2005 Apr; 65(8):3209-17. PubMed ID: 15833852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nuclear factor-kappaB (NF-kappaB): from a versatile transcription factor to a ubiquitous therapeutic target.
    Yates LL; Górecki DC
    Acta Biochim Pol; 2006; 53(4):651-62. PubMed ID: 17068636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
    Jiang J; Slivova V; Sliva D
    Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
    Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G
    Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the NF-kappaB axis in immune modulation of osteoclasts and bone loss.
    Abu-Amer Y; Darwech I; Otero J
    Autoimmunity; 2008 Apr; 41(3):204-11. PubMed ID: 18365833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-kappaB signaling: pros and cons of altering NF-kappaB as a therapeutic approach.
    Egan LJ; Toruner M
    Ann N Y Acad Sci; 2006 Aug; 1072():114-22. PubMed ID: 17057194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential.
    Wong ET; Tergaonkar V
    Clin Sci (Lond); 2009 Mar; 116(6):451-65. PubMed ID: 19200055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription.
    Scheidereit C
    Oncogene; 2006 Oct; 25(51):6685-705. PubMed ID: 17072322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.